This essay has been submitted by a student. This is not an example of the work written by professional essay writers.
Walking

Multiple sclerosis does not have a cure

This essay is written by:

Louis PHD Verified writer

Finished papers: 5822

4.75

Proficient in:

Psychology, English, Economics, Sociology, Management, and Nursing

You can get writing help to write an essay on these topics
100% plagiarism-free

Hire This Writer

Multiple sclerosis does not have a cure

  1. Treatment

Multiple sclerosis does not have a cure. Even so, various treatment strategies can speed recovery from MS-related attacks, alter its course, and manage subsequent symptoms. The primary goal of treating MS involves using therapies to prevent damaged areas (Gossman, “Treatment/Management”). During the 1990s, MS treatments were injectable, but medical and pharmacological advancements influenced the introduction of oral and infusion therapies. Primarily, modern therapies target the most common form of the disease – relapsing-remitting therapies. By 2017, the European Medicines Agency and US Food and Drug Administration approved the first therapy for primary progressive MS (“Treatment/Management”).

Disease-modifying agents are used in therapy to shorten the duration of acute exacerbations, curtail their frequency, and provide symptomatic relief. According to Goldenberg (177), disease-modifying treatments include intravenous dexamethasone and brief corticosteroids to maintain functioning and improve quality of life. The FDA and EMA have also licensed 12 products to control MS symptoms (Appendix Fig. 2). First-line therapy medication for relapsing-remitting MS includes Interferon-β-1a variants and Glatiramer (177). These drugs are efficient in curtailing the relapse rate, delaying neurological disability progression, and reducing the severity of ameliorating relapse. Dimethyl fumarate reduces the relapse rate by nearly 50% (178).

  1. Prognosis

Estimates show that close to half a million patients in the US suffer from the disease, subjecting approximately 50% of the patients to mobility assistance within 15 years after its onset (Goldenberg 175). Accordingly, more than half of the patients depend on walking aid or are on wheelchairs. Depression and suicide rate among MS patients is statistically higher compared to the general population (Ghasemi et al. 2). However, estimating the average longevity among MS patients remains a challenge considering that the disease varies with individuals. According to Huang et al., poor prognosis is mainly due to the advanced age of patients and an increased number of relapses in the early stages (3164). The most common reasons for MS patients’ death are secondary, compromised swallowing, challenges in breathing, chronic urinary tract infections, and immobility.

 

 

  Remember! This is just a sample.

Save time and get your custom paper from our expert writers

 Get started in just 3 minutes
 Sit back relax and leave the writing to us
 Sources and citations are provided
 100% Plagiarism free
error: Content is protected !!
×
Hi, my name is Jenn 👋

In case you can’t find a sample example, our professional writers are ready to help you with writing your own paper. All you need to do is fill out a short form and submit an order

Check Out the Form
Need Help?
Dont be shy to ask